Mycotic aneurysm of the ascending aorta due to Escherichia coli: a case report.

Escherichia coli; Mycotic aneurysm; ascending aorta; Anti-Bacterial Agents; Female; Humans; Aged; Aged, 80 and over; Aorta/diagnostic imaging; Anti-Bacterial Agents/therapeutic use; Aneurysm, Infected/diagnosis; Aneurysm, Infected/surgery; Aneurysm, Infected/drug therapy; Aortic Aneurysm/complications; Aortic Aneurysm/diagnosis; Aortic Aneurysm/surgery; Aneurysm, Infected; Aorta; Aortic Aneurysm; Cardiology and Cardiovascular Medicine; General Medicine

Abstract :

[en] Ascending aorta mycotic aneurysm is a rare entity. It is a life-threatening condition because of the possibility of aortic dissection, or rupture. Escherichia coli is recognised as an uncommon cause of aortic mycotic aneurysm. An 81-year-old woman with a history of Escherichia coli pyelonephritis 4 months previously, was admitted to our centre for a mycotic aneurysm of the ascending aorta caused by Escherichia coli. She was successfully treated by urgent in situ replacement of the ascending aorta with a cryopreserved homograft, combined with antibiotics. Although infrequent, Escherichia coli mycotic aneurysm should be suspected in older patients with atherosclerosis and who developed septicaemia. Prompt treatment with a combination of appropriate antibiotics and surgery is required.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Zekhnini, Ines; Department of Cardiovascular Surgery, CHU Liege, Liège, Belgium

Halleux, Danaé ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique

Durieux, Rodolphe ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique

DEFRAIGNE, Jean ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique

Radermecker, Marc ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique

Tchana-Sato, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique

Language :

English

Title :

Mycotic aneurysm of the ascending aorta due to Escherichia coli: a case report.

Publication date :

September 2022

Journal title :

Acta Cardiologica

ISSN :

0001-5385

eISSN :

1784-973X

Publisher :

Taylor and Francis Ltd., England

Volume :

Issue :

Pages :

643 - 646

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2021.1973774

Available on ORBi :

since 13 May 2023

Statistics

Number of views

57 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Gornik HL, Creager MA. Aortitis. Circulation. 2008; 117 (23): 3039–3051.
Cho S-J, Park S-M, Ryu S-M, et al. Nonaneurysmal infectious aortitis. Ann Vasc Surg. 2014; 28 (5): 1313.e13–1313.e16.
Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American heart Association. Circulation. 2016; 134 (20): e412–e460.
Akashi Y, Ikehara Y, Yamamoto A, et al. Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case report. Jpn Circ J. 2000; 64 (1): 83–86.
Ballaith A, Raffort J, Rajhi K, et al. Mycotic aortic and left iliac ruptured aneurysm due to Escherichia coli: a case report and literature overview. Acta Chir Belg. 2020; 21: 1–7.
Takagi H, Nachi S, Matsuno Y, et al. Chronic contained rupture of the descending thoracic aorta due to infection by Escherichia coli. Heart Vessels. 2005; 20 (4): 186–189.
Takahashi Y, Tsutsumi Y, Monta O, et al. Mycotic aneurysm of the thoracic aorta caused by extended-spectrum beta-lactamase-producing Escherichia coli. Interact Cardiovasc Thorac Surg. 2011; 12 (1): 61–62.
Helleman JN, Hendriks JMH, Deblier I, et al. Mycotic aneurysm of the descending thoracic aorta. Review and case report. Acta Chir Belg. 2007; 107 (5): 544–547.
Hsu R-B, Lin F-Y. Infected aneurysm of the thoracic aorta. J Vasc Surg. 2008; 47 (2): 270–276.
McCann JF, Fareed A, Reddy S, et al. Multi-resistant Escherichia coli and mycotic aneurysm: two case reports. J Med Case Rep. 2009; 3: 6453.
Rajendran R, Malik H, Richardson T. Escherichia coli and mycotic thoracic aortic aneurysm: a case report. Gd Rounds. 2012; 12 (1): 27–31.
Yano M, Hayase T, Furukawa K, et al. Mycotic pseudoaneurysm of the ascending aorta caused by Escherichia coli. Interact Cardiovasc Thorac Surg. 2013; 16 (1): 81–83.
Sörelius K, Wanhainen A, Wahlgren C-M, et al. Nationwide study on treatment of mycotic thoracic aortic aneurysms. Eur J Vasc Endovasc Surg. 2019; 57 (2): 239–246.
Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018; 360: k678.
Lee C-C, Lee M-TG, Chen Y-S, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral Fluoroquinolone. JAMA Intern Med. 2015; 175 (11): 1839–1847.
Carino D, Zafar MA, Singh M, et al. Fluoroquinolones and aortic diseases: is there a connection. Aorta. 2019; 7 (2): 35–41.
Coselli JS, Crawford ES, Williams TW, et al. Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg. 1990; 50 (6): 868–881.
Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999; 67 (6): 1990–1993; discussion 1997–1998.
Czerny M, von Allmen R, Opfermann P, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg. 2011; 92 (5): 1657–1662.
Corvera JS, Blitzer D, Copeland H, et al. Repair of thoracic and thoracoabdominal mycotic aneurysms and infected aortic grafts using allograft. Ann Thorac Surg. 2018; 106 (4): 1129–1135.